|
List
by Protocol Number
Informational
NCCTG N0392
Consent
HIPAA
Protocol
Assessment of Patient Satisfaction with Participation in Phase II/III NCCTG
Clinical Trials
NSABP LTS-01
Consent
HIPAA
Protocol
Patient Reported Outcomes in Long-term Survivors
with Colon and Rectal Cancer
Symptom Management
Ascites
NCCTG N04C2
Consent
HIPAA
Protocol
An
Exploratory, Randomized, Placebo-Controlled Trial of Depot Octreotide for
Symptomatic Ascites in Cancer Patients
Neuropathy
NCCTG N06CA Consent
HIPAA
Protocol
(permanent
closure effective 05/16/08)
The Use of Topical Baclofen, Amitriptyline HCl,
and Ketamine (BAK) in a PLO Gel vs. Placebo for
the Treatment of Chemotherapy Induced Peripheral
Neuropathy: A Phase III Randomized Double-Blind
Placebo Controlled Study
Fatigue
NCCTG N05C7 Consent HIPAA
Protocol
Long Acting Methylphenidate (Concerta™) for
Cancer-Related Fatigue: A Phase III Randomized,
Double-Blind Placebo Controlled Study
Ovarian Function Failure
SWOG S0230
Consent
HIPAA Fast
Facts
Protocol
Phase III Trial of LHRH Analog Administration During
Chemotherapy to Reduce Ovarian Failure Following Standard Adjuvant Chemotherapy in Early
Stage, Hormone-Receptor Negative Breast Cancer
Vaginal
Dryness
NCCTG N04CA Consent
HIPAA
Protocol
Pilocarpine for Vaginal Dryness:
A Phase III Randomized, Placebo-controlled, Double-blind Study
Hand
and Foot Syndrome
NCCTG N05C5
Consent
B
HIPAA
Protocol
A Phase III Randomized,
Placebo-controlled, Double-blind Trial to Determine the Effectiveness of a
Urea/Lactic Acid-based Topical Keratolytic Agent and Vitamin B-6 for Prevention
of Capecitabine-induced Hand and Foot Syndrome
Radiation
Oncology
RTOG R0518
Consent
HIPAA
Protocol
Supplemental Funding
Phase
III, Double-Blind, Placebo-Controlled Study to
Evaluate the Efficacy of Zometa for the
Prevention of Osteoporosis and Associated
Fractures in Patients Receiving Radiation
Therapy and Long-term LHRH Agonists for
High-Grade and/or Locally Advanced Prostate
Cancer
RTOG R0517
Consent
HIPAA
Protocol
Randomized Phase III trial to Evaluate
Radiopharmaceuticals and Zoledronic Acid in the
Palliation of Osteoblastic Metastases from Lung,
Breast and Prostate Cancer
|
